These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


555 related items for PubMed ID: 15173268

  • 21. Metabolites of a tobacco-specific carcinogen in urine from newborns.
    Lackmann GM, Salzberger U, Töllner U, Chen M, Carmella SG, Hecht SS.
    J Natl Cancer Inst; 1999 Mar 03; 91(5):459-65. PubMed ID: 10070946
    [Abstract] [Full Text] [Related]

  • 22. Exposure to nicotine and a tobacco-specific carcinogen increase with duration of use of smokeless tobacco.
    Hecht SS, Carmella SG, Edmonds A, Murphy SE, Stepanov I, Luo X, Hatsukami DK.
    Tob Control; 2008 Apr 03; 17(2):128-31. PubMed ID: 18375734
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. NNAL exposure by race and menthol cigarette use among U.S. smokers.
    Rostron B.
    Nicotine Tob Res; 2013 May 03; 15(5):950-6. PubMed ID: 23089487
    [Abstract] [Full Text] [Related]

  • 25. Evidence for endogenous formation of N'-nitrosonornicotine in some long-term nicotine patch users.
    Stepanov I, Carmella SG, Han S, Pinto A, Strasser AA, Lerman C, Hecht SS.
    Nicotine Tob Res; 2009 Jan 03; 11(1):99-105. PubMed ID: 19246447
    [Abstract] [Full Text] [Related]

  • 26. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in smokers in the United States: NHANES 2007-2008.
    Xia Y, Bernert JT, Jain RB, Ashley DL, Pirkle JL.
    Biomarkers; 2011 Mar 03; 16(2):112-9. PubMed ID: 21114376
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Association of Reduced Nicotine Content Cigarettes With Smoking Behaviors and Biomarkers of Exposure Among Slow and Fast Nicotine Metabolizers: A Nonrandomized Clinical Trial.
    Mercincavage M, Lochbuehler K, Wileyto EP, Benowitz NL, Tyndale RF, Lerman C, Strasser AA.
    JAMA Netw Open; 2018 Aug 03; 1(4):e181346. PubMed ID: 30627706
    [Abstract] [Full Text] [Related]

  • 30. Nicotine, Carcinogen, and Toxin Exposure in Long-Term E-Cigarette and Nicotine Replacement Therapy Users: A Cross-sectional Study.
    Shahab L, Goniewicz ML, Blount BC, Brown J, McNeill A, Alwis KU, Feng J, Wang L, West R.
    Ann Intern Med; 2017 Mar 21; 166(6):390-400. PubMed ID: 28166548
    [Abstract] [Full Text] [Related]

  • 31. Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer.
    Derby KS, Cuthrell K, Caberto C, Carmella S, Murphy SE, Hecht SS, Le Marchand L.
    Int J Cancer; 2009 Nov 15; 125(10):2418-24. PubMed ID: 19598261
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Exposure and Metabolic Activation Biomarkers of Carcinogenic Tobacco-Specific Nitrosamines.
    Hecht SS, Stepanov I, Carmella SG.
    Acc Chem Res; 2016 Jan 19; 49(1):106-14. PubMed ID: 26678241
    [Abstract] [Full Text] [Related]

  • 35. Metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone to its biomarker total NNAL in smokeless tobacco users.
    Hecht SS, Carmella SG, Stepanov I, Jensen J, Anderson A, Hatsukami DK.
    Cancer Epidemiol Biomarkers Prev; 2008 Mar 19; 17(3):732-5. PubMed ID: 18349296
    [Abstract] [Full Text] [Related]

  • 36. [Harm reduction strategy in tobacco control].
    Gorini G.
    Epidemiol Prev; 2011 Mar 19; 35(3-4 Suppl 1):19-32. PubMed ID: 21926451
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The relationship between nicotine metabolism and nicotine and carcinogen exposure among American Indian commercial cigarette smokers and electronic nicotine delivery system users.
    Carroll DM, Wagener TL, Stephens LD, Brame LS, Thompson DM, Beebe LA.
    Addict Behav; 2019 May 19; 92():58-63. PubMed ID: 30583092
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 28.